| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/05/2013 | CN101809162B Anti-glypican-3 antibody having improved kinetics in plasma |
| 06/05/2013 | CN101754978B Antigen associated with lung cancer and lymphoma |
| 06/05/2013 | CN101736017B Classical swine fever virus E2 subunit vaccine and preparation thereof |
| 06/05/2013 | CN101267834B 白介素-1偶联物及其用途 Interleukin-1 conjugates and their use |
| 06/05/2013 | CN101160402B Cancer specific antibody and cell surface proteins |
| 06/05/2013 | CN101056979B Anti-histone H1 monoclonal antibody and hybridoma capable of producing the same |
| 06/04/2013 | US8455629 Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
| 06/04/2013 | US8455626 Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| 06/04/2013 | US8455623 Compositions and methods for diagnosing and treating cancer |
| 06/04/2013 | US8455622 Variant target binding agents and uses thereof |
| 06/04/2013 | US8455614 PMMA binding peptides |
| 06/04/2013 | US8455446 Single domain TDF-related compounds and analogs thereof for use in treating a tissue differentiation factor related disorder |
| 06/04/2013 | US8455445 Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders |
| 06/04/2013 | US8455441 Antidotes for factor Xa inhibitors and methods of using the same |
| 06/04/2013 | US8455434 Methods of use for cysteine variants of human G-CSF |
| 06/04/2013 | US8455253 Using interleukins and colony stimulating factors to convert antigen presenting cells into dendritic cells for use in identifying modulators for treatment of infections, cell proliferative and autoimmune disorders |
| 06/04/2013 | US8455210 Biochip, and method for the selective identification of Chlamydia trachomatis infections |
| 06/04/2013 | US8454977 Non-toxic biofilm inhibitor |
| 06/04/2013 | US8454976 Recombinant toxin fragments |
| 06/04/2013 | US8454974 Adaptive mutations allow establishment of JFH1-based cell culture systems for hepatitis C virus genotype 4A |
| 06/04/2013 | US8454973 Modified human hepatitis C virus genomic RNA that can be autonomously replicated |
| 06/04/2013 | US8454972 Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen |
| 06/04/2013 | US8454969 Soluble tumor necrosis factor receptor mutant |
| 06/04/2013 | US8454968 Method for inducing immunity with a peptide fragment from human CAPRIN-1 |
| 06/04/2013 | US8454967 Compositions and methods for modulating the immune system |
| 06/04/2013 | US8454965 Method for the treatment of multiple sclerosis |
| 06/04/2013 | US8454964 Three dimensionally crosslinked agarose bead with grass pollen covalently bound; immunotherapy, vaccines, diagnosis |
| 06/04/2013 | US8454963 Tissue targeted complement modulators |
| 06/04/2013 | US8454962 Alpha-4-beta-7 heterodimer specific antagonist antibody |
| 06/04/2013 | US8454961 Alpha-4-beta-7 heterodimer specific antagonist antibody |
| 06/04/2013 | US8454960 Multispecific antibody targeting and multivalency through modular recognition domains |
| 06/04/2013 | US8454959 Compositions monovalent for CD28 binding and methods of use |
| 06/04/2013 | US8454958 Methods for detecting and inhibiting angiogenesis |
| 06/04/2013 | US8454956 Methods for treating rheumatoid arthritis and osteoporosis with anti-IL-20 antibodies |
| 06/04/2013 | US8454955 Methods for treating allergic airway inflammation, airway hypersensitivity, and eosinophilia |
| 06/04/2013 | US8454953 Methods for reducing allergies caused by environmental allergens |
| 06/04/2013 | US8454952 Augmentation of endothelial thromboresistance |
| 06/04/2013 | CA2615738C Bifunctional protein anchors |
| 06/04/2013 | CA2541709C Anti-pecam therapy for metastasis suppression |
| 06/04/2013 | CA2499926C Antibody against von willebrand factor cleaving enzyme and assay system using the same |
| 06/04/2013 | CA2228667C Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
| 06/02/2013 | CA2772180A1 Anti-npy and pyy antibodies and uses thereof |
| 05/30/2013 | WO2013078400A1 Virus vectors for highly efficient transgene delivery |
| 05/30/2013 | WO2013078393A1 Treating bladder cancer patients and identifying bladder cancer patients responsive to treatment |
| 05/30/2013 | WO2013078385A1 Methods of increasing neuronal differentiation using antibodies to lysophosphatidic acid |
| 05/30/2013 | WO2013078375A2 Administration of alpha4beta7 hetero-dimer-specific antibody |
| 05/30/2013 | WO2013078299A1 Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
| 05/30/2013 | WO2013078271A1 Method of treatment of tumors that are resistant to egfr therapies by egfr antibody cytotoxic agent conjugate |
| 05/30/2013 | WO2013078223A1 Anti-factor h binding protein antibodies and methods of use thereof |
| 05/30/2013 | WO2013078172A1 Tempo-mediated glycoconjugation of an immunogenic composition against campylobacter jejuni |
| 05/30/2013 | WO2013078135A2 Il-1 binding proteins |
| 05/30/2013 | WO2013078102A1 Method for preparation of aluminum hydroxyphosphate adjuvant |
| 05/30/2013 | WO2013078089A1 Anti-tim-1 antibodies and uses thereof |
| 05/30/2013 | WO2013077907A1 Methods of treating psoriatic arthritis (psa) using il-17 antagonists and psa response or non- response alleles |
| 05/30/2013 | WO2013077618A1 Pharmaceutical composition containing anti-kiaa1114 antibody as active ingredient for preventing or treating cancer induced by kiaa1114 over-expression |
| 05/30/2013 | WO2013077617A1 Composition for preventing, treating or alleviating atopic dermatitis comprising immunosuppressant and transglutaminase 2 inhibitor |
| 05/30/2013 | WO2013077458A1 Anti-human trop-2 antibody exhibiting antitumor activity in vivo |
| 05/30/2013 | WO2013077186A1 Activity modulator, medicinal agent comprising same, use of cd300a gene-deficient mouse, and anti-cd300a antibody |
| 05/30/2013 | WO2013076730A1 Methods of regulating angiogenesis and compositions capable of same |
| 05/30/2013 | WO2013076492A1 Malaria vaccine |
| 05/30/2013 | WO2013076268A1 Population of immunoregulatory t cells specific for an irrelevant antigen and uses thereof for preventing or treating immune diseases |
| 05/30/2013 | WO2013076183A1 Combination therapy using anti - cd20 antibody and human il-15 |
| 05/30/2013 | WO2013076167A1 Hla-dr7 hy epitope and method for treating leukemia |
| 05/30/2013 | WO2013075846A1 Pharmaceutical composition for treatment of allergic reactions |
| 05/30/2013 | WO2013075608A1 Chimeric recombinant antigen and use thereof |
| 05/30/2013 | WO2013075553A1 Superantigen fusion protein targeting cancer and preparation method and use thereof |
| 05/30/2013 | WO2013075382A1 Anti human her2 monoclonal antibody |
| 05/30/2013 | WO2013075266A1 Immune methods against influenza viruses and combinatorial vaccines thereof |
| 05/30/2013 | WO2013075185A1 Attenuated escherichia coli strains for septicemia in birds, vaccines produced using said strains, method for producing vaccines and uses thereof |
| 05/30/2013 | WO2013052772A3 Anti-human sema4a antibodies useful to treat disease |
| 05/30/2013 | WO2013043933A3 Cd27l antigen binding proteins |
| 05/30/2013 | WO2013014405A3 Methods of inhibiting inflammation comprising inhibiting cd63 |
| 05/30/2013 | WO2013012806A3 Protection of cells from alu-rna-induced degenereation and inhibitors for protecting cells |
| 05/30/2013 | WO2012047732A3 Antibody compositions and methods of use |
| 05/30/2013 | US20130137976 Functional, Cross-Linked Nanostructures for Tandem Optical Imaging and Therapy |
| 05/30/2013 | US20130137835 Preparation of Polyphosphazene Microspheres |
| 05/30/2013 | US20130137727 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 05/30/2013 | US20130137187 Synthetic active peptide fragments |
| 05/30/2013 | US20130136796 Acellular Bioabsorbable Tissue Regeneration Matrices |
| 05/30/2013 | US20130136775 Hydrophobic drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition |
| 05/30/2013 | US20130136774 Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition |
| 05/30/2013 | US20130136771 Oligodeoxynucleotide and its use to induce an immune response |
| 05/30/2013 | US20130136768 Recombinant HCMV and RHCMV vectors and uses thereof |
| 05/30/2013 | US20130136767 Compositions, methods and uses for poxvirus elements in vaccine constructs |
| 05/30/2013 | US20130136762 Modified surface antigen |
| 05/30/2013 | US20130136761 S. pneumoniae antigens |
| 05/30/2013 | US20130136760 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/30/2013 | US20130136758 Immunostimulating Polyphosphazene Compounds |
| 05/30/2013 | US20130136757 Methods of treating cancer using a combination of an immunomodulatory compound and an artemisinin or a derivative thereof |
| 05/30/2013 | US20130136754 Regulatory b cells and their uses |
| 05/30/2013 | US20130136749 Human CTLA-4 Antibodies And Their Uses |
| 05/30/2013 | US20130136747 Anti-amyloid beta antibodies and their use |
| 05/30/2013 | US20130136746 COMPOSITIONS AND METHODS RELATED TO PROTEIN A (SpA) ANTIBODIES AS AN ENHANCER OF IMMUNE RESPONSE |
| 05/30/2013 | US20130136744 Pulmonary administration of immunoglobulin single variable domains and constructs thereof |
| 05/30/2013 | US20130136743 Novel mutated humanized 12g4 antibodies and the fragments thereof against the human anti-mullerian hormone receptor type ii |
| 05/30/2013 | US20130136740 Methods of treating cancer |
| 05/30/2013 | US20130136737 Uses of NOGO-A Inhibitors and Related Methods |
| 05/30/2013 | US20130136735 HUMANIZED ANTIBODIES TO iNKT |
| 05/30/2013 | US20130136733 Stable Multi-Dose Compositions Comprising an Antibody and a Preservative |
| 05/30/2013 | US20130136718 Targeting interferon-lambda with antibodies potently enhances anti-tumor and anti-viral activities |